{"hands_on_practices": [{"introduction": "Gluconeogenesis is the metabolic equivalent of swimming upstream, requiring a significant energy investment to reverse the energetically favorable flow of glycolysis. This exercise focuses on a fundamental aspect of this pathway: its energetic cost. By tallying the total number of high-energy phosphate bonds from $ATP$ and $GTP$ needed to synthesize one molecule of glucose from lactate, you will gain a concrete understanding of why this process is so metabolically demanding and how it is coupled to energy-providing molecules [@problem_id:2047840].", "problem": "In metabolic biochemistry, gluconeogenesis is the pathway by which glucose is synthesized from non-carbohydrate precursors. This process is particularly active in the liver to maintain blood glucose levels during periods of fasting or intense exercise. Consider the synthesis of one molecule of glucose from two molecules of lactate in a liver cell. This multi-step process requires overcoming the irreversible steps of glycolysis by using a distinct set of enzymes and consumes energy in the form of high-energy phosphate bonds from Adenosine Triphosphate (ATP) and Guanosine Triphosphate (GTP). For the purpose of this problem, the hydrolysis of ATP to Adenosine Diphosphate (ADP) and inorganic phosphate, or the hydrolysis of GTP to Guanosine Diphosphate (GDP) and inorganic phosphate, each counts as the consumption of one high-energy phosphate bond.\n\nCalculate the total number of high-energy phosphate bonds required to synthesize one molecule of glucose starting from two molecules of lactate.", "solution": "Gluconeogenesis from two molecules of lactate to one molecule of glucose proceeds via pyruvate and requires ATP and GTP to bypass the irreversible steps of glycolysis. We count only hydrolyses of ATP to ADP and of GTP to GDP as one high-energy phosphate bond each.\n\n1) Lactate to pyruvate:\nTwo lactate are oxidized to two pyruvate by lactate dehydrogenase, producing two NADH:\n- No ATP or GTP is consumed here.\n- The two NADH produced will be used later in gluconeogenesis.\n\n2) Pyruvate carboxylase step:\nTwo pyruvate are carboxylated to two oxaloacetate, each requiring one ATP:\n$$2 \\times \\text{ATP} \\to 2 \\times \\text{ADP} + 2 \\times \\text{P}_{i}$$\nThis consumes $2$ high-energy phosphate bonds.\n\n3) Phosphoenolpyruvate carboxykinase step:\nTwo oxaloacetate are converted to two phosphoenolpyruvate, each requiring one GTP:\n$$2 \\times \\text{GTP} \\to 2 \\times \\text{GDP} + 2 \\times \\text{P}_{i}$$\nThis consumes $2$ high-energy phosphate bonds.\n\n4) 3-phosphoglycerate kinase step (reverse of glycolysis):\nTwo molecules of 3-phosphoglycerate are phosphorylated to two 1,3-bisphosphoglycerate, each requiring one ATP:\n$$2 \\times \\text{ATP} \\to 2 \\times \\text{ADP}$$\nThis consumes $2$ high-energy phosphate bonds.\n\n5) Glyceraldehyde-3-phosphate dehydrogenase step:\nTwo molecules of 1,3-bisphosphoglycerate are reduced to two glyceraldehyde-3-phosphate, consuming two NADH (generated in step 1). No ATP or GTP is consumed here.\n\n6) Remaining steps to glucose (aldolase, fructose-1,6-bisphosphatase, phosphoglucose isomerase, glucose-6-phosphatase) do not consume ATP or GTP.\n\nSumming the high-energy phosphate bonds:\n$$2\\ (\\text{ATP in pyruvate carboxylase}) + 2\\ (\\text{GTP in PEPCK}) + 2\\ (\\text{ATP in PGK}) = 6$$\nTherefore, synthesizing one glucose from two lactate requires $6$ high-energy phosphate bonds.", "answer": "$$\\boxed{6}$$", "id": "2047840"}, {"introduction": "Understanding a metabolic pathway requires more than just memorizing the sequence of intermediates; it involves tracking the fate of individual atoms. This practice utilizes the powerful biochemical technique of isotopic labeling to follow carbon atoms from the precursor glycerol into the final product, glucose [@problem_id:2047786]. By predicting the final position of a $^{13}C$ label, you will uncover the subtle yet crucial roles of enzymes like triose phosphate isomerase and aldolase in rearranging the carbon skeleton.", "problem": "In a liver cell actively performing gluconeogenesis, a supply of glycerol is introduced. The central carbon atom (C-2) of this glycerol is isotopically labeled with $^{13}$C. This labeled glycerol is then metabolized to synthesize new glucose molecules. Assuming that the triose phosphate isomerase enzyme maintains a rapid equilibrium between its substrates, which of the following options correctly identifies the carbon atom(s) in the resulting glucose molecule that will carry the $^{13}$C label? For the purpose of this problem, the carbons of glucose are numbered sequentially from the aldehyde group (C-1) to the terminal primary alcohol group (C-6).\n\nA. C-1 and C-6\n\nB. C-2 and C-5\n\nC. C-3 and C-4\n\nD. C-2 and C-4\n\nE. C-1 and C-5", "solution": "Let the glycerol carbons be numbered from one terminal primary alcohol to the other as C-1, C-2 (central), C-3. The label is on glycerol C-2.\n\nStep 1 (Activation and oxidation to DHAP): Glycerol is converted to glycerol-3-phosphate by glycerol kinase without changing the carbon skeleton, so the label remains at C-2. Glycerol-3-phosphate is then oxidized by glycerol-3-phosphate dehydrogenase to dihydroxyacetone phosphate (DHAP), again preserving the carbon framework, placing the label at DHAP C-2.\n\nTherefore,\n$$\\text{glycerol }(C\\!-\\!2)\\;\\longrightarrow\\;\\text{G3P }(C\\!-\\!2)\\;\\longrightarrow\\;\\text{DHAP }(C\\!-\\!2).$$\n\nStep 2 (Triose phosphate isomerase, rapid equilibrium): Triose phosphate isomerase interconverts DHAP and glyceraldehyde-3-phosphate (GAP) via an enediol intermediate without any carbon–carbon bond cleavage. The carbon positions are conserved along the three-carbon chain, so\n$$\\text{DHAP }(C\\!-\\!i)\\;\\longleftrightarrow\\;\\text{GAP }(C\\!-\\!i)\\quad\\text{for }i\\in\\{1,2,3\\}.$$\nHence the label initially at DHAP C-2 will also appear at GAP C-2 under rapid equilibrium.\n\nStep 3 (Aldolase condensation to fructose-1,6-bisphosphate): In gluconeogenesis, aldolase condenses one DHAP and one GAP to form fructose-1,6-bisphosphate (F1,6BP). The well-established carbon mapping for this condensation is:\n- DHAP C-1, C-2, C-3 map to F1,6BP C-1, C-2, C-3, respectively.\n- GAP C-1, C-2, C-3 map to F1,6BP C-4, C-5, C-6, respectively.\n\nTherefore, a label at DHAP C-2 yields a label at F1,6BP C-2, while a label at GAP C-2 yields a label at F1,6BP C-5.\n\nStep 4 (To glucose): F1,6BP is dephosphorylated to fructose-6-phosphate (F6P) by fructose-1,6-bisphosphatase without any carbon scrambling, and then isomerized to glucose-6-phosphate (G6P) by phosphoglucose isomerase. This aldose–ketose isomerization proceeds without carbon–carbon bond cleavage and preserves the carbon numbering along the chain; thus the carbon indices are retained:\n$$\\text{F1,6BP }(C\\!-\\!j)\\;\\to\\;\\text{F6P }(C\\!-\\!j)\\;\\to\\;\\text{G6P/glucose }(C\\!-\\!j).$$\n\nCombining Steps 3 and 4:\n- Label from DHAP C-2 → F1,6BP C-2 → F6P C-2 → glucose C-2.\n- Label from GAP C-2 → F1,6BP C-5 → F6P C-5 → glucose C-5.\n\nSince triose phosphate isomerase maintains rapid equilibrium, the labeled carbon from glycerol C-2 will populate both DHAP C-2 and GAP C-2, and hence the newly synthesized glucose will carry the label at C-2 and C-5.\n\nThus, the correct choice is C-2 and C-5.", "answer": "$$\\boxed{B}$$", "id": "2047786"}, {"introduction": "Metabolic pathways are not isolated chains of reactions but are intricately regulated and compartmentalized within the cell. This problem explores how gluconeogenesis adapts to different starting materials and the critical role of intercellular transport [@problem_id:2047841]. By analyzing the effect of a hypothetical inhibitor on glucose synthesis from lactate versus alanine, you will appreciate how the cell manages its redox balance, specifically the transport of $NADH$ reducing equivalents between the mitochondria and the cytosol.", "problem": "A pharmaceutical company is investigating a novel compound, \"Mito-Malatoblock,\" as a potential metabolic regulator. In vitro studies have confirmed that Mito-Malatoblock is a highly specific, non-competitive inhibitor of the mitochondrial isoform of malate dehydrogenase (mMDH). The compound has no effect on the cytosolic isoform of this enzyme (cMDH).\n\nTo understand its physiological impact, experiments are conducted using isolated liver cells (hepatocytes) capable of gluconeogenesis. The hepatocytes are cultured in two separate conditions. In both conditions, all necessary co-substrates and enzymes for glucose synthesis are available in non-limiting concentrations.\n\n- **Condition 1:** The sole gluconeogenic precursor provided is lactate.\n- **Condition 2:** The sole gluconeogenic precursor provided is alanine.\n\nAssuming the primary goal of the cell in both conditions is to synthesize glucose, predict the effect of adding a high concentration of Mito-Malatoblock to the cultures.\n\nWhich of the following statements most accurately describes the expected outcome?\n\nA. Gluconeogenesis from alanine will be severely inhibited, while gluconeogenesis from lactate will be largely unaffected.\n\nB. Gluconeogenesis from lactate will be severely inhibited, while gluconeogenesis from alanine will be largely unaffected.\n\nC. Gluconeogenesis will be severely inhibited in both conditions.\n\nD. Gluconeogenesis will be largely unaffected in both conditions.\n\nE. The rate of gluconeogenesis will be significantly increased in both conditions.", "solution": "Mitochondrial malate dehydrogenase (mMDH) catalyzes the reversible reaction in the mitochondrial matrix:\n$$\n\\text{oxaloacetate} + \\mathrm{NADH} + \\mathrm{H}^{+} \\leftrightarrow \\text{malate} + \\mathrm{NAD}^{+}.\n$$\nA non-competitive inhibitor decreases $V_{\\max}$ without changing $K_{m}$; under Michaelis–Menten kinetics the apparent maximum velocity is\n$$\nV_{\\max}^{\\prime}=\\frac{V_{\\max}}{1+\\frac{[I]}{K_{i}}},\n$$\nso at high inhibitor concentration with $[I]\\gg K_{i}$ one has $V_{\\max}^{\\prime}\\to 0$, essentially abolishing mMDH flux regardless of substrate concentrations. The inhibitor does not affect cytosolic MDH (cMDH).\n\nFor gluconeogenesis from lactate (Condition 1), cytosolic lactate dehydrogenase provides the necessary cytosolic reducing equivalents:\n$$\n\\text{lactate} + \\mathrm{NAD}^{+} \\to \\text{pyruvate} + \\mathrm{NADH} + \\mathrm{H}^{+}.\n$$\nPyruvate is carboxylated in the mitochondrion:\n$$\n\\text{pyruvate} + \\mathrm{CO}_{2} + \\mathrm{ATP} \\to \\text{oxaloacetate} + \\mathrm{ADP} + P_{i}.\n$$\nAlthough conversion of oxaloacetate to malate for export is blocked by mMDH inhibition, oxaloacetate carbon can exit the mitochondrion via transamination to aspartate and back, which does not require mMDH:\n$$\n\\text{mito-AST:}\\quad \\text{oxaloacetate} + \\text{glutamate} \\leftrightarrow \\text{aspartate} + \\alpha\\text{-ketoglutarate},\n$$\ntransport of aspartate to cytosol, then\n$$\n\\text{cyto-AST:}\\quad \\text{aspartate} + \\alpha\\text{-ketoglutarate} \\leftrightarrow \\text{oxaloacetate} + \\text{glutamate}.\n$$\nCytosolic oxaloacetate is then converted to phosphoenolpyruvate:\n$$\n\\text{oxaloacetate} + \\mathrm{GTP} \\to \\text{phosphoenolpyruvate} + \\mathrm{GDP} + \\mathrm{CO}_{2}.\n$$\nCritically, the cytosolic $\\mathrm{NADH}$ required for the glyceraldehyde-3-phosphate dehydrogenase step,\n$$\n1,3\\text{-bisphosphoglycerate} + \\mathrm{NADH} + \\mathrm{H}^{+} \\to \\text{glyceraldehyde-3-phosphate} + P_{i} + \\mathrm{NAD}^{+},\n$$\nis already supplied by the lactate dehydrogenase reaction. Therefore, with mMDH blocked, carbon export can proceed via the aspartate route and the redox requirement in the cytosol remains satisfied; gluconeogenic flux from lactate is largely unaffected.\n\nFor gluconeogenesis from alanine (Condition 2), alanine is first transaminated in the cytosol:\n$$\n\\text{alanine} + \\alpha\\text{-ketoglutarate} \\leftrightarrow \\text{pyruvate} + \\text{glutamate},\n$$\nwhich does not generate cytosolic $\\mathrm{NADH}$. The gluconeogenic pathway still requires cytosolic $\\mathrm{NADH}$ for the same glyceraldehyde-3-phosphate dehydrogenase reaction. Under normal conditions, these reducing equivalents are supplied by the malate–aspartate shuttle: mitochondrial oxaloacetate is reduced by mMDH,\n$$\n\\text{oxaloacetate} + \\mathrm{NADH} + \\mathrm{H}^{+} \\xrightarrow{\\text{mMDH}} \\text{malate} + \\mathrm{NAD}^{+},\n$$\nmalate is exported, and then reoxidized by cMDH in the cytosol,\n$$\n\\text{malate} + \\mathrm{NAD}^{+} \\xrightarrow{\\text{cMDH}} \\text{oxaloacetate} + \\mathrm{NADH} + \\mathrm{H}^{+},\n$$\nthereby generating cytosolic $\\mathrm{NADH}$. Because Mito-Malatoblock specifically inhibits mMDH, the initial reduction of oxaloacetate to malate cannot proceed at appreciable rate, malate export is prevented, and cytosolic $\\mathrm{NADH}$ is not produced by this shuttle. Even though oxaloacetate carbon could still be moved as aspartate, this route does not generate cytosolic $\\mathrm{NADH}$; consequently the glyceraldehyde-3-phosphate dehydrogenase step cannot sustain flux, and gluconeogenesis from alanine is severely inhibited.\n\nTherefore, inhibition of mMDH selectively impairs gluconeogenesis from alanine while leaving gluconeogenesis from lactate largely unaffected.", "answer": "$$\\boxed{A}$$", "id": "2047841"}]}